Adenosine 3′-phosphate 5′-phosphosulfate lithium salt hydrate
SIGMA/A1651 - ≥60%
Synonym: 3′-Phosphoadenosine 5′-phosphosulfate lithium salt; APPS; Active sulfate; PAPS
CAS Number: 109434-21-1
Empirical Formula (Hill Notation): C10H15N5O13P2S · xLi+ · yH2O
Molecular Weight: 507.26 (free acid basis)
Linear Formula: C10H15N5O13P2S · xLi+ · yH2O
Product Type: Chemical
concentration | ≥60% |
form | powder |
InChI | 1S/C10H15N5O13P2S.4Li.H2O |
InChI key | UGODCLHJOJPPHP-AZGWGOJFSA |
Quality Level | 200 |
shipped in | dry ice |
storage temp. | −70°C |
Application: | 3′-Phosphoadenosine 5′-phosphosulfate (PAPS) is used as a universal sulfonate donor for in vivo sulfonation by sulfotransferases. PAPS is used for the sulfation of glycans. PAPS is also useful to study the distribution and function of its biological transporter(s). |
Application: | Adenosine 3′-phosphate 5′-phosphosulfate lithium salt has been used in a study that cloned and characterized a mammalian lithium-sensitive bisphosphate 3′-nucleotidase inhibited by inositol 1,4-bisphosphate. Adenosine 3′-phosphate 5′-phosphosulfate lithium salt has also been used in a study to assess the golgi-resident PAP-specific 3′-phosphatase-coupled sulfotransferase assays. |
Caution: | Rapid decomposition occurs when exposed to room temperature: up to 17% per day at 37 °C. We ship on dry ice to minimize decomposition in transit. |
Packaging: | 1, 5, 25 mg in glass bottle |
Quality: | Major impurities appear to be adenosine 3′,5′-diphosphate, sulfate and ammonia substitution products. |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | −70°C |
UNSPSC | 41106305 |